Hologic Growth Aided By 3D Mammography System Sales Overseas
This article was originally published in The Gray Sheet
Executive Summary
Women’s health firm Hologic reported 13.1% growth in its breast health segment in its fiscal fourth quarter, to $197.7 million, aided in part by overseas sales of its Selenia Dimensions three-dimensional digital mammography system, the firm announced Nov. 8.
You may also be interested in...
Digital Mammography Systems Are Now 510(k) Products – FDA Final Rule
Two-dimensional digital mammography systems, such as those made by Hologic and GE Healthcare, can now enter the market through the 510(k) versus PMA route, according to a final rule and special controls guidance issued Nov. 4.
Hologic Looks Ahead To Reimbursement, Training For 3D Mammography
Hologic is already looking ahead to reimbursement and training requirements for its Selenia Dimensions 3D three-dimensional digital mammography system as it works with FDA on final pre-market approval issues, the company says
Hologic Selenia 3D Digital Mammography System Gets Panel Nod
FDA's Radiological Devices Advisory Panel unanimously endorsed safety and efficacy data on Hologic's Selenia Dimensions 3D three-dimensional digital mammography system for screening and diagnosis of breast cancer at a Sept. 24 meeting